Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | 12-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100 | 120 | 1,490 | N/A | 0 |
| Receivables | 2,130 | 1,500 | 610 | 400 | 402 |
| Other current assets | 220 | 310 | 100 | 40 | 46 |
| TOTAL | $2,450 | $1,930 | $2,200 | $440 | $447 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 2,387 |
| Other Non-Current Assets | 1,270 | 1,330 | 1,180 | 880 | 767 |
| TOTAL | $1,270 | $1,330 | $1,180 | $880 | $3,153 |
| Total Assets | $9,190 | $7,020 | $5,870 | $3,200 | $3,601 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 100 | 100 | 70 | 80 | 86 |
| Accounts payable and accrued liabilities | 1,080 | 600 | 280 | 0 | 349 |
| Accrued Expenses | 1,220 | 630 | 210 | N/A | 0 |
| Other current liabilities | N/A | N/A | N/A | N/A | 168 |
| TOTAL | $4,610 | $2,510 | $1,240 | $960 | $961 |
| Non-Current Liabilities | |||||
| Long Term Debt | 610 | 540 | 230 | 800 | 335 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 471 |
| TOTAL | $4,060 | $3,020 | $2,470 | $2,690 | $2,698 |
| Total Liabilities | $8,920 | $5,750 | $3,890 | $3,650 | $3,658 |
| Shareholders' Equity | |||||
| Retained earnings | -2,040 | -800 | 20 | -450 | -162 |
| Other shareholders' equity | -10 | 0 | 10 | -4 | 0 |
| TOTAL | $270 | $1,270 | $1,970 | $-450 | $-58 |
| Total Liabilities And Equity | $9,190 | $7,020 | $5,860 | $3,200 | $3,601 |